These assessments can be confounded by the effects of symptomatic medications, such as the involuntary dyskinesias induced by Levodopa, dopamine agonists, MAO-B inhibitors, and COMT (catechol-o-methyltransferase) inhibitors [256–258]. This evidence concerns the gene COMT and drug-induced dyskinesia.